{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-23-008963","form_type":"8-K","ticker":"VNRX","cik":"0000093314","company_name":"VOLITIONRX LTD","filed_at":"2023-12-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:32.455273+00:00","generated_at":"2026-06-07T18:30:32.910272+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"VolitionRx secures ~$5.5M financing from Belgian regional government WE","bullets":["Total financing €5.0M (~$5.5M) from Wallonie Entreprendre; €2.5M unsecured loan at 8% interest, maturity Dec 2028.","€2.5M equity component: WE purchases 3,205,431 restricted shares at $0.8337 per share.","Proceeds for Nu.Q product development, including Nu.Q NETs sepsis diagnostic clinical program.","Loan drawable in three tranches: €1.5M immediate, €0.5M from June 2024, €0.5M from March 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-23-008963","json":"https://secwatch.observer/filing/0001477932-23-008963.json","markdown":"https://secwatch.observer/filing/0001477932-23-008963.md","text":"https://secwatch.observer/filing/0001477932-23-008963.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/93314/000147793223008963/0001477932-23-008963-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/93314/000147793223008963/vnrx_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T18:30:32.910272+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}